CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
- 15 May 2008
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 76 (1-2), 80-84
- https://doi.org/10.1016/j.brainresbull.2008.01.010
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's diseaseBrain, 2006
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathologica, 2006
- Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2005
- Heterogeneity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer DiseaseArchives of Neurology, 2005
- [18F]FDG-PET in Patients with Alzheimer’s Disease: Marker of Disease SpreadDementia and Geriatric Cognitive Disorders, 2004
- Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairmentActa Neurologica Scandinavica, 2003
- The neural substrates of episodic memory impairment in Alzheimer’s disease as revealed by FDG–PET: relationship to degree of deteriorationBrain, 2002
- Review of the next generation of Alzheimer's disease therapeutics: challenges for drug developmentProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2001
- CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's DiseaseMolecular Neurobiology, 2001
- CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective StudyExperimental Neurology, 2000